Related Experiment Video

Updated: Mar 5, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

[Hypogonadism in patients with testicular tumors and prostate cancer]

Marcin Radko1, Tomasz Syryło2, Henryk Zieliński2

  • 1Klinika Urologii Onkologicznej, Czynnościowej I Ogólnej, Centralny Szpital Kliniczny - Wojskowy Instytut Medyczny, Warszawa, Polska, Centrum Płodności Fertimedica, Warszawa, Polska.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|March 27, 2017
PubMed

Insights

Hypogonadism, a deficiency in androgens, impairs fertility and affects overall health. Cancer patients, especially those with testicular or prostate cancer, face a high risk of this condition, often left untreated.

Area of Science:

  • Urology
  • Endocrinology
  • Oncology

Background:

  • Hypogonadism involves androgen deficiency, leading to testicular dysfunction.
  • It negatively impacts fertility, organ function, physical well-being, sexual health, and mental state.
  • Cancer patients, particularly those with testicular tumors and prostate cancer, are at high risk.

Purpose of the Study:

  • To highlight the prevalence and impact of hypogonadism in cancer patients.
  • To emphasize the need for addressing hypogonadism in urological oncology.

Main Methods:

  • Review of existing literature on hypogonadism and cancer treatment.
  • Analysis of symptoms and consequences of androgen deficiency in affected patient groups.

Main Results:

  • Hypogonadism significantly affects multiple bodily systems and overall quality of life.
  • Cancer treatments are a primary cause of hypogonadism in these patients.
  • Symptoms are frequently overlooked and undertreated.

Conclusions:

  • Hypogonadism is a serious complication in cancer survivors, particularly those treated for urological malignancies.
  • Increased awareness and proactive management of hypogonadism are crucial for improving patient outcomes.
Keywords:
prostate cancertesticular tumorstestosteronehypogonadism

More Related Videos

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

7.0K
Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

47.9K

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.3K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
629
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
2.7K
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
124.2K
Testes: Gross Anatomy01:19

Testes: Gross Anatomy

The testes, also known as testicles, are the male gonads. They are housed within the scrotum, a sac-like structure located beneath the penis. The scrotum's primary role is to regulate the temperature of the testes, which is crucial for sperm production.
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
7.4K